Norway - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Norway Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry was up 0.1% year on year. In 2019, the country was ranked number 28 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $36,963,598.93 Million PPP. Norway is overtaken by Greece, which was number 27 at $83,431,205.22 Million PPP and is followed by Chile with $28,786,954.1 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, that is an increase of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
Date | Million US Dollars PPP |
---|---|
2019 | 36,963,598.93 |
2018 | 37,760,935.15 |
2017 | 40,809,121.46 |
2016 | 35,457,833.91 |
2015 | 33,253,265.38 |
How does Norway rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
# | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
27 |
#27
Greece
|
83,431,205.22 | 2019 | +0.1 % | +0.1 % | View data | |
28 |
#28
Norway
|
36,963,598.93 | 2019 | -2.1 % | +0.1 % | View data | |
29 |
#29
Chile
|
28,786,954.10 | 2015 | +2.7 % | +15.9 % | View data |